Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer
Clinical trial NCT04289974 · UNKNOWN
Trial details
- NCT number
- NCT04289974
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-02-14
- Primary completion
- 2020-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.